It’s not for this market.” Overall, STX ranks 3rd on our list of stocks that Jim Cramer talked about. While we acknowledge the potential of STX as an investment, our conviction lies in the belief that ...
Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third ... control of STX-478, described as a next-generation PI3K ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback